Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Journal of Medicinal Chemistry
|
July 22, 1994
6-Azasteroids: structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase
S V Frye, C D Haffner, P R Maloney, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
December 3, 2014
Outcome reporting in bariatric surgery: an in-depth analysis to inform the development of a core outcome set, the BARIACT Study
J C Hopkins, N Howes, K Chalmers, et al.
British Journal of Pharmacology
|
July 17, 2001
Endothelium-derived hyperpolarizing factor and potassium use different mechanisms to induce relaxation of human subcutaneous resistance arteries
C A McIntyre, C H Buckley, G C Jones, et al.
International Journal of Obesity (2005)
|
July 4, 2017
Enabling recruitment success in bariatric surgical trials: pilot phase of the By-Band-Sleeve study
S Paramasivan, C A Rogers, R Welbourn, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 15, 2017
Exercise to preserve β-cell function in recent-onset Type 1 diabetes mellitus (EXTOD) - a randomized controlled pilot trial
P Narendran, N Jackson, A Daley, et al.
Lancet (London, England)
|
June 28, 2011
Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial
R C Andrews, A R Cooper, A A Montgomery, et al.
Journal of Medicinal Chemistry
|
November 16, 2001
Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)
M H Rabinowitz, R C Andrews, J D Becherer, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 16, 2001
Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases
J G Conway, R C Andrews, B Beaudet, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 22, 2001
N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution
D L Musso, M W Andersen, R C Andrews, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Journal of Medicinal Chemistry
|
July 22, 1994
6-Azasteroids: structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase
S V Frye, C D Haffner, P R Maloney, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
December 3, 2014
Outcome reporting in bariatric surgery: an in-depth analysis to inform the development of a core outcome set, the BARIACT Study
J C Hopkins, N Howes, K Chalmers, et al.
British Journal of Pharmacology
|
July 17, 2001
Endothelium-derived hyperpolarizing factor and potassium use different mechanisms to induce relaxation of human subcutaneous resistance arteries
C A McIntyre, C H Buckley, G C Jones, et al.
International Journal of Obesity (2005)
|
July 4, 2017
Enabling recruitment success in bariatric surgical trials: pilot phase of the By-Band-Sleeve study
S Paramasivan, C A Rogers, R Welbourn, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
September 15, 2017
Exercise to preserve β-cell function in recent-onset Type 1 diabetes mellitus (EXTOD) - a randomized controlled pilot trial
P Narendran, N Jackson, A Daley, et al.
Lancet (London, England)
|
June 28, 2011
Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial
R C Andrews, A R Cooper, A A Montgomery, et al.
Journal of Medicinal Chemistry
|
November 16, 2001
Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)
M H Rabinowitz, R C Andrews, J D Becherer, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 16, 2001
Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases
J G Conway, R C Andrews, B Beaudet, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 22, 2001
N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution
D L Musso, M W Andersen, R C Andrews, et al.
Page
of 4